
GenrAb
GenrAb is harnessing the power of innate human immunity to develop therapies that can protect and treat patients with neurological diseases.
$5.6M Seed ·
Source: startupintros.com
Funding history ↓Signals
Website registeredOct 10, 2022 (4 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Seed | $5.6M | — | startupintros.com |
Timeline
- Website created
Companies like GenrAb
AAstrocyte Pharmaceuticals$9.5M Series B+ · Sep 2026
CCayuga Biotech
PPretzel TherapeuticsSeries A · Sep 2022SSynuCa TherapeuticsSeed · Mar 2026
RRetrotopeSeries B+ · Aug 2021SStorm Therapeutics$56M Series B+ · Apr 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/genrab (get a free API key).